Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T0373 |
Erlotinib
OSI-744,NSC 718781,CP358774,埃罗替尼,R1415 |
EGFR; Autophagy | Angiogenesis; Autophagy; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Erlotinib (NSC-718781) 是一种直接作用的EGFR 酪氨酸激酶抑制剂,用于治疗非小细胞肺癌,对人 EGFR 的IC50为 2 nM。它可降低完整肿瘤细胞的 EGFR 自磷酸化,IC50为 20 nM。 | |||
T0373L |
Erlotinib hydrochloride
盐酸埃罗替尼,OSI-744,NSC 718781,Erlotinib HCl,CP-358774 |
EGFR; Autophagy | Angiogenesis; Autophagy; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Erlotinib hydrochloride (NSC 718781) 抑制EGFR 激酶的IC50为 2 nM,用于治疗非小细胞肺癌。 | |||
T0373L1 |
Erlotinib mesylate
CP-358774,CP-358,774,埃罗替尼甲磺酸盐,OSI-774,CP358774,OSI 774 |
||
Erlotinib is an epidermal growth factor receptor inhibitor. Erlotinib binds in a reversible fashion to the adenosine triphosphate (ATP) binding site of the receptor. | |||
T11229 |
Erlotinib-d6
OSI-774 D6,NSC 718781 D6,CP-358774 D6 |
Others | Others |
Erlotinib is a directly acting inhibitor EGFR tyrosine kinase inhibitor with an IC50 of 2 nM for human EGFR. Erlotinib D6 is a deuterium labeled Erlotinib . | |||
T19312 |
Erlotinib-d6 hydrochloride
CP-358774 D6 hydrochloride,NSC 718781 D6 hydrochloride,Erlotinib D6 hydrochloride,OSI-774 D6 hydrochloride |
Others | Others |
Erlotinib Hydrochloride inhibits purified EGFR kinase with an IC50 of 2 nM. Erlotinib D6 hydrochloride a deuterium labeled Erlotinib Hydrochloride. |